This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hill, M. N. Search for Related Content PubMed PubMed Citation Articles by Hill, M. N.

(Circulation. 1998;97:1221-1222.)
© 1998 American Heart Association, Inc.

Editorials

New Targeted AHA Research Program

Cardiovascular Care and Outcomes

Martha N. Hill, RN, PhD, President of the American Heart Association

Correspondence to Martha N. Hill, PhD, RN, Johns Hopkins University, 525 Wolfe St, Baltimore, MD 21205-2110.

Key Words: Editorials • AHA Medical/Scientific Statements • prevention • patient care

As noted in my Presidential Address at the 70th Scientific Sessions of the American Heart Association,¹ cardiovascular disease and stroke remain the No. 1 and No. 3 causes of death, respectively, of all Americans.² This is due in part to a gap that exists between effective interventions in clinical trials to improve patient care and outcomes and daily practice of healthcare professionals as well as daily behavior of patients and the public.^{3 4 5 6 7 8 9 10 11 12} To increase its contribution to the AHA's mission, which is to reduce morbidity and mortality due to heart disease and stroke, the AHA research program continues to support talented researchers who are advancing our knowledge about genetics, as well as meritorious behavioral and clinical research reviewed through the Behavioral Science, Epidemiology, and Prevention Study Group created 5 years ago. The AHA has recently undergone dramatic changes in organizational structure and processes to increase efficiency and effectiveness in meeting its mission. These changes have led to the development of more highly focused efforts in communications, public advocacy, fund-raising, and education to leverage AHA's resources as the leading nongovernment agency fighting heart disease and stroke.

Another topic discussed in my President's Address was the importance of establishing science priorities and developing effective strategies for achieving goals related to the AHA's mission. The AHA must consider the full spectrum of science, from investigations of mechanisms with the basic sciences studied in the laboratory, to investigations of therapies with the clinical sciences studied in healthcare settings, to investigations of prevention with the . . . [Full Text of this Article]

This article has been cited by other articles:

				S. Windecker, W. Maier-Rudolph, T. Bonzel, G. Heyndrickx, J.M. Lablanche, M.C. Morice, V. Muhlberger, K.L. Neuhaus, F. Piscione, M. van den Brand, et al. Interventional cardiology in Europe 1995 Eur. Heart J., April 1, 1999; 20(7): 484 - 495. [Abstract] [PDF]